CORMEDIX INC. - COMMON STOCK

CorMedix Inc. Announces Executive Leadership Changes

04 окт 2021 15:01:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Regulatory Update

07 сен 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update

12 авг 2021 15:01:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12

28 июл 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

10 июн 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference

09 июн 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference

27 май 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

13 май 2021 15:01:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Appointment of Chief Commercial Officer

13 май 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13

05 май 2021 07:00:02 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit

28 апр 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA

14 апр 2021 08:00:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference

07 апр 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

30 мар 2021 15:05:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30

23 мар 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

15 мар 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Contract Extension of Liz Masson-Hurlburt as Executive Vice President and Head of Clinical Operations

11 мар 2021 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Host Regulatory Update Conference Call

08 мар 2021 16:00:00 Источник Nasdaq GlobeNewswire

CorMedix Receives Complete Response Letter From FDA for DefenCath™ Catheter Lock Solution

01 мар 2021 07:30:00 Источник Nasdaq GlobeNewswire